Recently exited
RKLB · Rocket Lab Corporation
Last analysed ·
Current thesis
Rocket Lab's stabilisation case rests on operating growth absorbing acquisition dilution after its September 15 funding announcement. Iridium approval on 2026-09-24 followed by a weekly close above $64.26 confirms the narrow case only if a weekly close below $60 has not occurred first.
Kill line
A weekly close below $60 invalidates the stabilisation thesis. A failed or postponed Iridium vote on 2026-09-24 separately invalidates the published catalyst timetable.
Pick status
Open commitment catalyst in 4dscored if the kill line above fires How this is scored →Latest analysis and events for RKLB —
As of 20 September 2026, the latest FrontierPicks analysis for Rocket Lab Corporation (RKLB): 16 July 2026: Piper Sandler initiated Neutral, PT $83 — FIRST post-Iridium coverage launch and it landed BELOW spot and below the entire 6-raise June 30 cluster ($96 Cantor floor, $130 Citizens/Roth ceiling). Target band now brackets price instead of sitting above it. A second Neutral or a downgrade from an existing bull confirms the raise cycle is over.
Kill line: A weekly close below $60 invalidates the stabilisation thesis. A failed or postponed Iridium vote on 2026-09-24 separately invalidates the published catalyst timetable.
Next dated event on file: — catalyst in 4d.
Current Thesis
Rocket Lab's stabilisation case now rests on operating growth absorbing acquisition dilution; Iridium approval on 2026-09-24 followed by a weekly close above the September 4 market reference of $64.26 would confirm it, provided a weekly close below $60 has not occurred first. The September 18 adjusted close of $64.57 clears that reference before the vote, leaving the required post-approval confirmation outstanding.
The financing question has changed since September 11. Rocket Lab announced on 2026-09-15 that its at-the-market equity offering raised approximately $1.944 billion gross, Iridium's existing loan agreement was amended, and the $3.6 billion bridge commitment was terminated. Funding availability is no longer the same unresolved issue described in the previous note; dilution and completion conditions remain relevant. Company financing announcement
As an inference from the financing milestone and September 18 price recovery above the published reference, the narrative is maturing — the case has moved toward absorbing disclosed funding costs and resolving the shareholder vote. This revises the September 11 saturation assessment without claiming broader participation. A weekly close below $60 would contradict that stabilisation reading.
Bullish and bearish views on Rocket Lab Corporation
The model's bull view on Rocket Lab Corporation (RKLB), in brief: Operating growth remains measurable. Rocket Lab's 2026-08-10 results reported second-quarter revenue of $234.07 million, up 62% year over year, and a generally accepted accounting principles gross margin of 36.1%. Third-quarter revenue below the $250 million guidance floor… The bear view: Equity supply is now documented. The 2026-09-15 announcement disclosed issuance of 29.3 million company shares. Financing completion therefore does not mean the acquisition avoided dilution. Financing announcement Approval does not complete acquisition. Rocket Lab's 2026-09-15… Both cases follow in full.
Bull Case
- Operating growth remains measurable. Rocket Lab's 2026-08-10 results reported second-quarter revenue of $234.07 million, up 62% year over year, and a generally accepted accounting principles gross margin of 36.1%. Third-quarter revenue below the $250 million guidance floor issued that day would contradict the operating-growth premise.
- Backlog documents contracted demand. The 2026-08-10 results reported backlog of $2.36 billion, up 137% year over year. Its conversion timetable remains essential: backlog alone does not establish when revenue will be recognised.
- Launch execution advanced after Friday. Rocket Lab announced on 2026-09-19 that Electron delivered Synspective's twelfth StriX satellite to orbit, marking its seventeenth launch of 2026. This adds completed operating execution after the September 18 reference close, without establishing a subsequent market response. Mission announcement
Bear Case
- Equity supply is now documented. The 2026-09-15 announcement disclosed issuance of 29.3 million company shares. Financing completion therefore does not mean the acquisition avoided dilution. Financing announcement
- Approval does not complete acquisition. Rocket Lab's 2026-09-15 announcement still expected completion in mid-2027, pending regulatory approvals. The September shareholder vote cannot establish completed integration or realised acquisition benefits. Company timetable
- The broader decline remains substantial. Through 2026-09-18, the adjusted market series shows a three-month price decline of 35.6% and a price 57.0% below its trailing annual high. Clearing the September reference establishes only a narrow recovery condition.
Setup & Price Structure
The 2026-09-18 adjusted daily close was $64.57, and the 14-day relative strength index was 50.5. The $64.26 reference comes from the market's September 4 close retained in the September 11 published thesis. The $60 weekly-close boundary remains the published thesis-break condition; it is not newly demonstrated technical support.
Benzinga's 2026-09-16 weekly recap grouped launch activity, analyst coverage and acquisition financing in one article. Its supplied September 18 headline then focused on dilution. These observations establish clustered coverage, not crowded ownership; the sample is too small to support a claim about investor positioning. September 16 coverage
No current moving-average value, ownership-flow series or short-interest observation is available in the dated evidence. Distance above a rising moving average and the breadth of participation therefore remain unmeasured.
Catalyst Calendar (next 30 days)
- 2026-09-24 — Iridium shareholder meeting. The filed proxy schedules the virtual meeting for 8:30 a.m. Eastern Time to consider the merger agreement. Approval satisfies the shareholder condition; rejection or postponement contradicts the dated approval case. A subsequent weekly close above $64.26 remains necessary for the published stabilisation outcome. Filed proxy statement
No additional company-confirmed earnings date within the next 30 days is established by the reviewed evidence. The third-quarter revenue test remains relevant, but an unverified release date is not assigned.
What Would Change Our Mind
Loss of the published recovery boundary would end the price thesis: a weekly close below $60 invalidates it. The September 18 close above the September 4 reference does not settle the case because it precedes the scheduled vote.
Iridium approval on 2026-09-24 followed by a weekly close above $64.26 would establish the narrow stabilisation outcome. Rejection or postponement would instead invalidate the catalyst timetable. Separately, third-quarter revenue below the $250 million floor announced on 2026-08-10 would break the operating premise even if the price boundary remained intact.
Correlation Notes
This is a single-name stabilisation case rather than a demonstrated space-sector recovery. Benzinga's supplied 2026-09-17 SpaceX coverage places the companies in adjacent headlines, but headline proximity does not measure return correlation. No paired return series supports a numerical correlation claim. The September 24 Iridium decision remains company-specific, so a peer rally alone would not satisfy the published confirmation condition.
Notes
- 2026-04-18: seed: Serenity/attention list
- 2026-05-20: $3B ATM equity program filed with 16 banks — discretionary supply ceiling near record highs; this is a NEW structural negative the original re-entry gate did not price. Track 8-K/424B5 for actual issuance volume.
- 2026-06-05: S&P declined to create a SpaceX index-inclusion catalyst — removes the speculation bid the proxy basket front-ran; space complex crashed on the news.
- 2026-07-16: Piper Sandler initiated Neutral, PT $83 — FIRST post-Iridium coverage launch and it landed BELOW spot and below the entire 6-raise June 30 cluster ($96 Cantor floor, $130 Citizens/Roth ceiling). Target band now brackets price instead of sitting above it. A second Neutral or a downgrade from an existing bull confirms the raise cycle is over.
- Iridium collar: 0.4000 RKLB shares at or below a $67.50 ten-day VWAP, 0.2400 at or above $112.50, plus $27.00 cash. Outside date 2027-06-28.
- The collar reference is measured over the ten trading days ending two full trading days before the first effective time — at closing, not at the 2026-09-24 vote.
- Guided Q3 basic weighted shares of 641M include roughly 41M Series A convertible participating preferred, so the figure is not comparable to common shares outstanding.
- The $981M NITE-STAR and $17B NSSL Phase 3 Lane 1 figures are shared IDIQ ceilings across several providers, not Rocket Lab awards; task and delivery orders are the conversion measure.
- Issuance under the $3B at-the-market programme surfaces only in 10-Q, 8-K and 424B5 filings, never in press releases. Neutron has not flown.
- Five-year beta 2.63. The company goes quiet before each quarterly release, so financing and schedule news tends to surface in the release itself.
Related · shared themes
IRDM
Iridium Communications Inc
Iridium Communications’ merger-discount thesis now has completed financing behind it; acquisition completion before a weekly close below $43.50 settles the case. Rocket Lab’s 2026-09-15 funding announcement advances the transaction, while the 2026-09-24 shareholder vote and regulatory approvals remain unresolved.
SPCX
SpaceX (Space Exploration Technologies Corp.)
SpaceX’s compute expansion now has a price breakout behind it; September capacity delivery and the December contract start test revenue conversion. A weekly close below $146.15 invalidates the breakout thesis.
ARXS
Arxis, Inc.
Arxis’ defense-and-space acquisition story needs another revenue-guidance increase at the next quarterly report to confirm acceleration. The case requires organic growth to hold at the 21% reported on 2026-07-29 and ends first if a weekly close falls below $50.
ASTS
AST SpaceMobile, Inc.
AST SpaceMobile’s spectrum-access recovery requires a disclosed Grain agreement and a weekly close above $62.40 by 2026-11-05. A weekly close below $55.74 would invalidate the case first.